Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
disruptions data and network analysis, the candidate should have a strong background in network modelling and coding. The selected candidate will also have excellent leadership ability/potential and strong
-
Koziarski Lab - The Hospital for Sick Children | Central Toronto Roselawn, Ontario | Canada | 1 day ago
focus on developing generative models for small molecule design. The candidate will contribute to the development of chemistry-informed generative models using frameworks such as generative flow networks
-
is part of a broader research initiative encompassing fundamental studies of nonlinear quantum light–matter interactions leading to the realization of quantum photonic neural networks. The successful
-
networks and performing GRN inference, Single-cell RNA-seq, perturb-seq, and/or other transcriptomic analysis, Next generation sequencing and bioinformatics analysis, Machine learning/AI; making, evaluating
-
opportunity to establish a Canada wide network and reputation and an excellent foundation from which to launch into a diverse palette of careers spanning from research faculty and management to health
-
Objective The objective of the BC NEIHR Postdoctoral Fellowships program is to provide funding to Indigenous (First Nations, Métis or Inuit) postdoctoral applicants who wish to conduct research within a British Columbia (BC) host institution. Recipients of these fellowships demonstrate...
-
poisoning in emergency departments using data derived from the Canadian Emergency Department Research Network. The incumbent may also have the opportunity to participate in real-world drug safety and
-
, policy, energy conversion, new business models, techno-economic and life cycle analyses, machine learning, optimization, AI, intelligent networks, among others. The PDF will join a project in collaboration
-
of the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). We are seeking scientists to lead research projects with a specific focus on the genetic determinants of severe adverse drug and vaccine reactions
-
laboratory of Dr. Bruce Carleton and the multi-centre research team of the Canadian Pharmacogenomics Network for Drug Safety (CPNDS). We are seeking scientists to lead research projects with a specific focus